Related Experiment Video
Updated: Oct 15, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
First Manic Attack During COVID-19 Treatment: A Case Report
Nalan Varsak1, Mert Topaloğlu2, Elif Özdemir2
1Department of Psychiatry, Malazgirt State Hospital, Muş, Turkey.
Abstract:
On March 11, 2020, the World Health Organization declared that the infection of novel coronavirus identified in Wuhan, China, is a pandemic. Various studies have shown that SARS-CoV-2 infection can trigger psychiatric effects such as anxiety, depression, and bipolar disorder. Here, we reported a case with no significant psychiatric history who experienced first-episode mania during the COVID-19 treatment. On the third day of hospitalization, the patient's mood was elevated, she thought she can treat other patients with her special power, she was talkative and irritable. Olanzapine 20 mg was started and the patient's score on the Young Mania Rating Scale decreased on the 17th day. Psychiatric outcomes associated with covid 19 are just emerging and it seems likely to be a potential engagement for psychiatric professionals in the future. More studies are required in terms of the treatment, course, and follow-up of psychiatric sequelae in these patients.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Myocarditis III: Medical Management
Bipolar Disorder
Myocarditis II: Clinical Features and Diagnostic Tests
Panic Disorder
Endocarditis III: Medical Management

